Adam de Havenon, MD, describes the challenges of effectively treating intracranial atherosclerotic disease, a cause of ischemic stroke, which is a leading cause of long-term disability and death.
Intracranial atherosclerosis: the most common and challenging cause of stroke in the world
Dr deHavenon discloses grant funding from NIH/NINDS, Regeneron Pharmaceuticals and AMAG pharmaceuticals.